Confidence with just one dose^1,2

RUCONEST^®: fast,^1-4 effective,^1,2 sustained relief⁵ for acute HAE attacks in just one dose^1,2

HAE Background

HAE arises from a deficiency in functional C1 esterase inhibitor (C1-INH), which can have potentially life threatening implications.^6,7

RUCONEST^® uses recombinant technology to restore C1-INH levels in the blood, targeting the root cause of HAE attacks.^8-10

RUCONEST^®: fast,^1,3,4 effective,¹ sustained relief^4,5 for acute HAE attacks in just one dose^1,2

Ruconest^® is generally well tolerated based on both clinical and patient registry data.^1,3,11,12

RUCONEST^® has proven efficacy in children, patients with a higher body mass index (BMI), and is suitable for emergency room use.^1,2-5,13-15

How can RUCONEST^® help your patients achieve their treatment goals?

References

Li H, et al. J Allergy Clin Immunol Pract 2015;3(3):417-423.
Valerieva A, et al. World Allergy Organ J 2021;14(4):100535.
Riedl M, et al. Ann Allergy Asthma Immunol 2013;110:295-299.
Riedl M, et al. Ann Allergy Asthma Immunol 2014;112(2):163-169.
Bernstein J, et al. Ann Allergy Asthma Immunol 2017;118(4):452-455.
Cancian M, et al. Pediatr Allergy Immunol 2020;31 Suppl 24:22-24.
European Value Dossier: RUCONEST. in the management of Acute Hereditary Angioedema. IQVIA, 2018.
Riedl M. Clin Drug Investig 2015;35(7):407-417.
van Veen H, et al. J Biotechnol 2012;162(2-3):319-326.
Feussner A, et al. Transfusion 2014;54:2566-2573.
Zuraw B, et al. J Allergy Clin Immunol 2010 Oct;126(4):821-827.
Moldovan D, et al. Clin Exp Allergy 2012 Jun;42(6):929-935.
Farrell C, et al. Br J Clin Pharmacol 2013;76(6):897-907.
RUCONEST^® SmPC. Jun 2021.
Reshef A, et al. Pediatr Allergy Immunol. 2019;30(5):562-568.